Literature DB >> 16254110

Atrophic gastritis in young children and adolescents.

O Ricuarte1, O Gutierrez, H Cardona, J G Kim, D Y Graham, H M T El-Zimaity.   

Abstract

BACKGROUND: Helicobacter pylori associated gastric cancer arises via a multistage process, with atrophic gastritis being the precursor lesion. Helicobacter pylori is typically acquired in childhood, yet little is known of the prevalence of atrophic gastritis in childhood. AIM: To study atrophic gastritis among children from countries with high gastric cancer incidence.
METHODS: Sections from topographically mapped gastric biopsy specimens from children undergoing clinically indicated endoscopy in Korea and Colombia were evaluated using visual analogue scales. Atrophy was defined as loss of normal glandular components, including replacement with fibrosis, intestinal metaplasia (IM), and/or pseudopyloric metaplasia of the corpus (identified by the presence of pepsinogen I in mucosa that was topographically corpus but phenotypically antrum).
RESULTS: One hundred and seventy three children, 58 from Korea (median age, 14 years) and 115 from Colombia (median age, 13 years), were studied. Helicobacter pylori was present in 85% of Colombian children versus 17% of Korean children (p<0.01). Atrophic mucosa near the antrum-corpus border was present in 16% of children, primarily as pseudopyloric metaplasia (31%, IM; 63%, pseudopyloric metaplasia; 6%, both). The median age of children with corpus atrophy was 15 (range, 7-17) years.
CONCLUSION: Gastric atrophy occurs in H pylori infected children living in countries with high gastric cancer incidence. Identification and characterisation of the natural history of H pylori gastritis requires targeted biopsies to include the lesser and greater curve of the corpus, starting just proximal to the anatomical antrum-corpus junction, in addition to biopsies targeting the antrum and cardia.

Entities:  

Mesh:

Year:  2005        PMID: 16254110      PMCID: PMC1770773          DOI: 10.1136/jcp.2005.026310

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  41 in total

1.  Carcinoma and intestinal metaplasia of the stomach in Colombian migrants.

Authors:  P Correa; C Cuello; E Duque
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  Clinical and pathological importance of cagA-positive Helicobacter pylori strains in children with abdominal complaints.

Authors:  M Korzon; G Sikorska-Wiśniewska; Z Jankowski; J Kur; P Banach
Journal:  Helicobacter       Date:  1999-12       Impact factor: 5.753

3.  The African enigma: low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African adults and children.

Authors:  D I Campbell; B F Warren; J E Thomas; N Figura; J L Telford; P B Sullivan
Journal:  Helicobacter       Date:  2001-12       Impact factor: 5.753

4.  Helicobacter pylori infection and recurrent abdominal pain in Turkish children.

Authors:  H Ozen; G Dinler; Y Akyön; N Koçak; A Yüce; F Gürakan
Journal:  Helicobacter       Date:  2001-09       Impact factor: 5.753

5.  Gastric intestinal metaplasia: subtypes and natural history.

Authors:  H M El-Zimaity; J Ramchatesingh; M A Saeed; D Y Graham
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

6.  Patterns of gastric atrophy in intestinal type gastric carcinoma.

Authors:  Hala M T El-Zimaity; Hiroyoshi Ota; David Y Graham; Taiji Akamatsu; Tsutomu Katsuyama
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

Review 7.  Pediatric gastrointestinal mucosal biopsy. Special considerations in children.

Authors:  P Gillett; E Hassall
Journal:  Gastrointest Endosc Clin N Am       Date:  2000-10

8.  Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients.

Authors:  O Gutierrez; J G Kim; T Akamatsu; I E Gürer; A E Simjee; D Y Graham
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

Review 9.  Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading.

Authors:  M Rugge; P Correa; M F Dixon; R Fiocca; T Hattori; J Lechago; G Leandro; A B Price; P Sipponen; E Solcia; H Watanabe; R M Genta
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

10.  Intensity of inflammation, density of colonization and interleukin-8 response in the gastric mucosa of children infected with Helicobacter pylori.

Authors:  Margarita Camorlinga-Ponce; Francisco Aviles-Jimenez; Lourdes Cabrera; Rogelio Hernández-Pando; Onofre Muñoz; Jorge Soza; Javier Torres
Journal:  Helicobacter       Date:  2003       Impact factor: 5.753

View more
  27 in total

Review 1.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

2.  Correlation of serum antibody titres with invasive methods for rapid detection of Helicobacter pylori infections in symptomatic children.

Authors:  Khaled Abdulqawi; Abeer M El-Mahalaway; Amer Abdelhameed; Alsayed A Abdelwahab
Journal:  Int J Exp Pathol       Date:  2012-08       Impact factor: 1.925

3.  Gastric cancer surveillance or prevention plus targeted surveillance.

Authors:  David Y Graham
Journal:  Jpn J Helicobacter Res       Date:  2009

4.  Autoimmune gastritis presenting as iron deficiency anemia in childhood.

Authors:  Cristina Gonçalves; Maria Emília Oliveira; Ana M Palha; Anabela Ferrão; Anabela Morais; Ana Isabel Lopes
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

5.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

6.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

Review 7.  Diagnosis: gastric intestinal metaplasia - what to do next?

Authors:  David Y Graham; Massimo Rugge; Robert M Genta
Journal:  Curr Opin Gastroenterol       Date:  2019-11       Impact factor: 3.287

8.  Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years.

Authors:  Gotaro Masuda; Akira Tokunaga; Takashi Shirakawa; Akiyoshi Togashi; Teruo Kiyama; Shunji Kato; Norio Matsukura; Hideki Bou; Masanori Watanabe; Takashi Tajiri
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

Review 9.  Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009.

Authors:  Jeannette Guarner; Nicolas Kalach; Yoram Elitsur; Sibylle Koletzko
Journal:  Eur J Pediatr       Date:  2009-07-18       Impact factor: 3.183

10.  Endoscopic and histopathologic findings associated with H. pylori infection in very young children.

Authors:  Engin Tutar; Deniz Ertem; Esin Kotiloglu Karaa; Ender Pehlivanoglu
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.